secwatch.observer — SEC 8-K summary
======================================

Issuer:     SRx Health Solutions, Inc. (SRXH)
CIK:        0001471727
Form:       8-K
Filed at:   2026-08-19T15:50:35+00:00
Accession:  0001493152-26-039162
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SRX Global Q3 net sales up 27% YoY; NAV $3.22/share beats estimate; declares dividend, buyback
--------------------------------------------------------------------------------

- Q3 net sales $3.4M, up 27% YoY; operating loss improved 63% to $3.2M; net loss from continuing ops $4.1M, improved 40% YoY
- NAV $62.9M or $3.22/share, above $3.07 preliminary estimate; $36.7M cash, $65.2M current assets, $2.4M liabilities, no debt
- Completed EMJX acquisition June 16, 2026; EMJX model max drawdown 10.6% vs 28-58% benchmarks; 4.3% gain in 14-day period vs Bitcoin -10.8%
- Declared one-time $0.05/share dividend (~$1.3M); approved 10M share repurchase program; 1-for-60 reverse split effective July 6, 2026
- Halo fill rates 93% avg, 98% in June; record Prime Day with 13% NTB growth, CPC $2.51 (8% below pet benchmark)

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1471727/000149315226039162/0001493152-26-039162-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1471727/000149315226039162/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-039162

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer